Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly : results of a prospective multicenter clinical trial

MLA

Caron, Pj, et al. Tumor Shrinkage with Lanreotide Autogel 120 Mg as Primary Therapy in Acromegaly : Results of a Prospective Multicenter Clinical Trial. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bbe4c9adf02c6458fc2730abcdd42cd2&authtype=sso&custid=ns315887.

APA

Caron, P., Bevan, J., Petersenn, S., Flanagan, D., Tabarin, A., Prévost, G., Maisonobe, P., Clermont, A., Van Gaal Luc, L., Marek, J., Nuutila, P., Välimäki, M., Ajzenberg, C., Borson Chazot, F., Brue, T., Caron, P., Chabre, O., Chanson, P., Rudelli, C., … Trainer, P. (2014). Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly : results of a prospective multicenter clinical trial.

Chicago

Caron, Pj, Js Bevan, S Petersenn, D Flanagan, A Tabarin, G Prévost, P Maisonobe, et al. 2014. “Tumor Shrinkage with Lanreotide Autogel 120 Mg as Primary Therapy in Acromegaly : Results of a Prospective Multicenter Clinical Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bbe4c9adf02c6458fc2730abcdd42cd2&authtype=sso&custid=ns315887.